Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Caris Life Sciences Inc (CAI)

Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26 PR Newswire - Mon Feb 9, 7:30AM CST

IRVING, Texas , Feb. 9, 2026 /PRNewswire/ --  Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...

CAI : 19.85 (-4.80%)
Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan PR Newswire - Wed Jan 28, 7:30AM CST

IRVING, Texas , Jan. 28, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published...

CAI : 19.85 (-4.80%)
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results PR Newswire - Mon Jan 12, 7:30AM CST

Full year revenue growth of approximately 94% driven by strong performance  in molecular profiling services

CAI : 19.85 (-4.80%)
Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect PR Newswire - Mon Jan 12, 7:00AM CST

IRVING, Texas , Jan. 12, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 19.85 (-4.80%)
Caris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire - Mon Jan 5, 7:30AM CST

IRVING, Texas , Jan. 5, 2026 /PRNewswire/ -- Caris Life Sciences ®  (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 19.85 (-4.80%)
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute PR Newswire - Fri Dec 19, 2025

IRVING, Texas , Dec. 19, 2025 /PRNewswire/ --  Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...

CAI : 19.85 (-4.80%)
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need PR Newswire - Tue Dec 16, 2025

IRVING, Texas , Dec. 16, 2025 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 19.85 (-4.80%)
Financial Pressure Turns Healthcare AI From Pilots Into Profits BayStreet.ca - Fri Dec 12, 2025

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER – Baystreet.ca News Commentary – Healthcare providers shortened buying cycles from eight months to under seven as financial pressures...

VPT.VN : 0.110 (-4.35%)
CCLD : 2.46 (-1.60%)
ABSI : 2.67 (-3.96%)
LNAI : 0.5750 (-0.38%)
CAI : 19.85 (-4.80%)
VPTDF : 0.0829 (-1.89%)
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium PR Newswire - Thu Dec 4, 2025

IRVING, Texas , Dec. 4, 2025 /PRNewswire/ --  Caris Life Sciences ®  (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 19.85 (-4.80%)
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute PR Newswire - Tue Dec 2, 2025

IRVING, Texas , Dec. 2, 2025 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 19.85 (-4.80%)

Barchart Exclusives

Dear IonQ Stock Fans, Mark Your Calendars for February 25 Barchart - 44 seconds ago
Weakness in this quantum computing stock is a buy opportunity. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot